Trending Industry Today: JOINN Leads Losses In CRO Stocks

Moomoo NewsJul 17 02:30 ET

Policy, industry, and capital converge: a critical window emerges for innovative drugs

Amid the confluence of multiple positive factors, the long-term growth thesis for innovative pharmaceuticals continues to strengthen, with rising certainty in valuation recovery and earnings realization in the second half of the year, further bolstering market confidence in the sector’s long-term growth prospects.

Zhitong FinanceJul 16 19:06 ET

Oligonucleotide Synthesis Market Worth $32.72 Billion by 2031 - Exclusive Report by MarketsandMarkets

PR NewswireJul 16 10:30 ET

Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement

MT NewswiresJul 16 02:26 ET

Accelerated partnerships and influx of industry giants propel AI-driven drug discovery into commercial fast lane

A Goldman Sachs research report indicates that AI can shorten drug time-to-market by approximately 20% to 25%, reduce the R&D process by about three years, and potentially lower overall development costs by roughly 25% to 30%.

Zhitong FinanceJul 15 19:08 ET

Selected HKEX Announcements | Datang New Energy Reports ~10% Decline in Power Generation in H1; Zhongtai Futures Expects Mid-Year Profit to Rise Nearly Threefold Year-on-Year

① Datang New Energy's electricity generation declined by approximately 10% in the first half of the year—how did it perform in June? ② Zhongtai Futures expects its interim profit to increase nearly threefold year-over-year; which business segments contributed to this growth?

cls.cnJul 15 08:49 ET